Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
470,5 USD | +0,69% |
|
-2,28% | +15,04% |
17/06 | VERTEX PHARMACEUTICALS INCORPORATED : Argus bevestigt koopadvies | ZM |
14/06 | Vertex Pharmaceuticals zegt dat gen-editing therapie klinische voordelen laat zien in proeven met genetische ziekten | MT |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,04% | 121 mld. | |
+18,16% | 112 mld. | |
+4,43% | 22,57 mld. | |
-18,19% | 20,82 mld. | |
-14,58% | 16,3 mld. | |
-16,61% | 16,19 mld. | |
-43,53% | 16,17 mld. | |
+1,58% | 13,17 mld. | |
+24,85% | 11,11 mld. | |
+107,26% | 10,57 mld. |
- Beurs
- Aandelen
- Koers VRTX
- Nieuws Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at JP Morgan 37th Annual Healthcare conference, Jan-07-2019 11